Table 2.

Clinicopathological variables of patients used for detection of circRNA100395 expression in prostate cancer

Clinicopathological variable	n
Age
≤65 years	32
>65 years	41
PSA
Low (0–10 ng/mL)	12
High (>10 ng/mL)	61
Gleason score
≤7	43
>7	30
Tumor size, cm
≤1 cm	40
>1 cm	33
Lymph-node metastasis
Yes	34
No	39
Tumor stage
T1+T2	43
T3+T4	30
Total	73

PSA, prostate-specific antigen.